Great Work Continues at SwanBio!

I was thrilled to read today about the mouse data that they announced today: human ABCD1 shows dose-responsive expression and activity To my untrained eye, this is fabulous news, and so much better than the plethora of ways that we have seen to lower VLCFA. To actually move on our mutated gene sure looks greatContinue reading “Great Work Continues at SwanBio!”

Partnering to fight AMN together

First let me say, on behalf of everyone at SwanBio Therapeutics, how much we admire and respect the platform Brad has created here with his blog. The voices of people dealing with AMN are the ones that rise to the top when we make decisions. For readers who don’t know us, SwanBio is targeting diseasesContinue reading “Partnering to fight AMN together”